Showing results (7291-7300 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|September 29, 2012
Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolismLora Mak, Sonia Liggi, Lu Tan, et al.Current Pharmaceutical Design|September 29, 2012
Rejuvenating sirtuins: the rise of a new family of cancer drug targetsSantina Bruzzone, Marco Daniele Parenti, Alessia Grozio, et al.Current Pharmaceutical Design|September 29, 2012
Glycogen synthase kinase 3 as an anticancer drug target: novel experimental findings and trends in the design of inhibitorsDmitry I Osolodkin, Vladimir A Palyulin, Nikolay S ZefirovCurrent Pharmaceutical Design|September 29, 2012
Heart rate as a therapeutic target in angina pectorisEmmanuel Androulakis, Dimitris Tousoulis, Nikolaos Papageorgiou, et al.Current Pharmaceutical Design|July 4, 2012
PDE5 inhibitor treatment options for urologic and non-urologic indications: 2012 updateSerap Gur, Philip J Kadowitz, Ege Can Serefoglu, et al.Current Pharmaceutical Design|July 4, 2012
Non-analgesic effects of opioids: the interaction of opioids with bone and jointsConsalvo Mattia, Eleonora Di Bussolo, Flaminia ColuzziCurrent Pharmaceutical Design|July 4, 2012
Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitationFlaminia Coluzzi, Alessandra Rocco, Ilenia Mandatori, et al.Current Pharmaceutical Design|July 4, 2012
Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systemsJohn P Headrick, Salvatore Pepe, Jason N PeartPageof 1,009